Business · 21/09/2020Updated: 10/17/2026 · 1 min read
FDA Withdraws COVID-19 Convalescent Plasma Guidance
Summary
The Food and Drug Administration (FDA) is withdrawing its final guidance for industry on Investigational COVID-19 Convalescent Plasma, issued in April 2020, due to the issuance of a new guidance with the same title.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →